V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20220747 | 20084066 | 1.86 | 81 | Palliative (P) | 2018-09-23 | 2018-09-23 | Enzalutamide | N | N | CAPECITABINE + TEMOZOLOMIDE | 101606636 |
| 20220758 | 20084067 | 1.77 | 57 | Adjuvant (A) | 2019-05-01 | 2019-05-01 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100140128 |
| 20220760 | 20084068 | 1.66 | 53.1 | Curative (C) | 2020-01-10 | 2020-01-18 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101238818 |
| 20220762 | 20084069 | 1.75 | 66.2 | Palliative (P) | 2016-07-19 | 2016-07-19 | CARBOPLATIN + PACLITAXEL + RT | 2 | N | OXALIPLATIN + RALTITREXED | 101856407 |
| 20220766 | 20084070 | 1.72 | 95.25 | Palliative (P) | 2019-04-06 | 2019-04-20 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100747184 |
| 20220773 | 20084071 | 1.76 | 84.3 | null | 2018-01-30 | 2018-02-06 | Enzalutamide | N | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100005997 |
| 20220778 | 20084072 | 1.68 | 85.5 | Palliative (P) | 2018-05-09 | 2018-05-24 | Enzalutamide | 02 | N | CETUXIMAB | 100854304 |
| 20220783 | 20084073 | 1.7 | 59.6 | 03 | null | 2017-06-26 | Enzalutamide | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100913676 |
| 20220784 | 20084074 | 1.53 | null | null | 2016-04-12 | 2016-04-27 | Enzalutamide | N | null | CETUXIMAB | 100981795 |
| 20220786 | 20084075 | 1.76 | 79 | Palliative (P) | 2017-05-29 | 2017-06-05 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + RT | 101738919 |
| 20220788 | 20084076 | 1.74 | 79.8 | Curative (C) | 2019-10-16 | 2019-10-16 | OCTREOTIDE | 02 | Y | ECF | 101559008 |
| 20220796 | 20084077 | 1.64 | 72.6 | Palliative (P) | 2018-01-12 | 2018-01-18 | Enzalutamide | null | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100424166 |
| 20220797 | 20084078 | 1.54 | 80 | Palliative (P) | null | 2019-10-24 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101648762 |
| 20220799 | 20084079 | null | 90.9 | Palliative (P) | 2016-01-27 | 2016-02-23 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100066351 |
| 20220800 | 20084080 | 1.64 | 81.5 | Curative (C) | 2019-12-20 | 2019-12-20 | Enzalutamide | 02 | N | CARBOPLATIN | 100941969 |
| 20220803 | 20084081 | 1.75 | 80.1 | Neo-adjuvant (N) | 2016-07-24 | 2016-07-25 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100915913 |
| 20220806 | 20084082 | 1.79 | 68 | Palliative (P) | null | 2018-07-21 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100351419 |
| 20220812 | 20084083 | 1.48 | 56.9 | Curative (C) | 2017-11-14 | 2017-11-30 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101122621 |
| 20220816 | 20084084 | 0 | 88.9 | Curative (C) | 2016-11-12 | 2016-12-03 | Cisplatin | null | N | CISPLATIN | 101114329 |
| 20220818 | 20084085 | 1.7 | 93.3 | Curative (C) | 2018-12-11 | 2018-12-11 | Enzalutamide | null | N | OCTREOTIDE | 100026253 |
| 20220820 | 20084086 | 0 | null | Palliative (P) | 2018-12-02 | 2018-12-02 | Enzalutamide | 02 | N | CETUXIMAB | 101817856 |
| 20220821 | 20084087 | 1.77 | 75.4 | Palliative (P) | null | 2019-10-02 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101368643 |
| 20220826 | 20084088 | 1.7 | 71 | Palliative (P) | 2018-05-27 | 2018-05-27 | Enzalutamide | 02 | N | CETUXIMAB | 100672924 |
| 20220827 | 20084089 | null | 83.2 | null | 2018-12-07 | 2018-12-22 | Oxaliplatin + Raltitrexed | N | null | OXALIPLATIN + RALTITREXED | 101831305 |
| 20220831 | 20084090 | 1.77 | 66.4 | null | 2018-12-30 | 2019-01-05 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN + RT | 100991263 |
| 20220833 | 20084091 | 1.6 | 50.9 | Palliative (P) | 2019-08-22 | 2019-08-22 | Enzalutamide | N | N | ECF | 101740835 |
| 20220838 | 20084092 | 1.72 | 80.5 | null | 2019-06-07 | 2019-06-07 | Enzalutamide | 02 | null | CARBOPLATIN + GEMCITABINE | 100014790 |
| 20220841 | 20084093 | 1.5 | 51.6 | Palliative (P) | 2014-10-05 | 2014-10-15 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100804566 |
| 20220842 | 20084094 | 1.65 | 76 | Palliative (P) | 2018-06-26 | 2018-07-02 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100089777 |
| 20220846 | 20084095 | 1.83 | 67.65 | Neo-adjuvant (N) | 2018-11-09 | 2018-11-09 | Enzalutamide | 02 | Y | TRASTUZUMAB | 100709450 |
| 20220849 | 20084096 | 1.57 | 100.75 | Neo-adjuvant (N) | 2019-06-07 | 2019-06-23 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101425574 |
| 20220858 | 20084097 | 1.63 | 80 | Palliative (P) | 2016-04-25 | 2016-05-20 | Enzalutamide | N | N | CETUXIMAB | 100514105 |
| 20220859 | 20084098 | 1.82 | null | null | 2019-08-02 | 2019-08-02 | Enzalutamide | 02 | null | TRASTUZUMAB | 100534883 |
| 20220860 | 20084099 | 1.59 | 70.1 | Palliative (P) | 2018-09-17 | 2018-10-01 | Enzalutamide | N | N | ENZALUTAMIDE | 100304418 |
| 20220863 | 20084100 | 1.69 | 81.5 | null | 2019-04-25 | 2019-04-30 | Cisplatin | 02 | null | CARBOPLATIN | 100459269 |
| 20220864 | 20084101 | 1.83 | 90 | null | 2018-08-19 | 2018-09-06 | Enzalutamide | 02 | null | CISPLATIN | 100086352 |
| 20220869 | 20084102 | 1.66 | 60.5 | 03 | 2018-01-15 | 2018-02-11 | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101598133 |
| 20220871 | 20084103 | 1.77 | 71.5 | null | 2020-07-25 | 2020-08-08 | Enzalutamide | 02 | null | CARBOPLATIN | 100997186 |
| 20220875 | 20084104 | 1.81 | 65.7 | Curative (C) | 2019-09-14 | 2019-10-05 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100082521 |
| 20220877 | 20084105 | 1.9 | 93.9 | Curative (C) | 2017-10-19 | 2017-11-07 | Enzalutamide | null | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100992867 |
| 20220878 | 20084106 | 1.51 | 69 | Curative (C) | 2021-04-14 | 2021-04-14 | Enzalutamide | 02 | N | TRASTUZUMAB | 100268403 |
| 20220883 | 20084107 | 1.91 | 89.8 | null | 2016-10-20 | 2016-10-21 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + OXALIPLATIN + MDG | 100563295 |
| 20220884 | 20084108 | 0 | 66.9 | Disease modification (D) | 2019-06-11 | 2019-06-25 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101613488 |
| 20220886 | 20084109 | 1.68 | 73 | 02 | 2021-04-14 | 2021-04-25 | Enzalutamide | N | N | CETUXIMAB + OXALIPLATIN + MDG | 101791976 |
| 20220887 | 20084110 | 1.59 | 89 | null | 2019-07-13 | 2019-07-19 | Enzalutamide | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 101364293 |
| 20220890 | 20084111 | 1.8 | 76.6 | Palliative (P) | 2018-08-06 | 2018-08-06 | Enzalutamide | null | N | ECF | 100182854 |
| 20220892 | 20084112 | 1.67 | 71.5 | Palliative (P) | null | 2016-11-15 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101127258 |
| 20220895 | 20084113 | 1.68 | 86 | null | 2016-01-15 | 2016-01-15 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101755447 |
| 20220896 | 20084114 | 1.7 | 66 | null | 2016-09-22 | 2016-09-24 | Enzalutamide | null | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100136464 |
| 20220899 | 20084115 | 1.6 | 50.1 | Palliative (P) | 2017-08-06 | 2017-08-06 | Capecitabine + Cisplatin + RT | 02 | N | ENZALUTAMIDE | 101251117 |